Literature DB >> 27011704

Unidirectional ventricular septal valved patch for repair of late presenting ventricular septal defect with aortopulmonary window.

Neeti Makhija1, Jitin Narula1, Vikas Kumar Keshri1, Saurabh Kumar Gupta1, Sachin Talwar1.   

Abstract

Management of long standing left to right shunt lesion resulting in elevated pulmonary vascular resistance (PVR) is challenging. Limited surgical options are further complicated by an unpredictable postoperative period. Unidirectional valve patch (UVP) closure has shown to be useful in cases of the large ventricular septal defect (VSD) who present late. We report a case of large aortopulmonary window coexisting with a large VSD with severe pulmonary artery hypertension and significantly elevated PVR that was managed surgically by closure of the window by sandwich technique and closure of the septal defect with a UVP. This report emphasizes the importance of UVP in the management of such patients.

Entities:  

Keywords:  Aortopulmonary window; pulmonary hypertension; valved patch; ventricular septal defect

Year:  2016        PMID: 27011704      PMCID: PMC4782481          DOI: 10.4103/0974-2069.171404

Source DB:  PubMed          Journal:  Ann Pediatr Cardiol        ISSN: 0974-5149


  9 in total

1.  Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension.

Authors:  Sachin Talwar; Shiv Kumar Choudhary; Sanket Garg; Anita Saxena; Sivasubramanian Ramakrishnan; Shyam Sunder Kothari; Rajnish Juneja; Balram Airan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-08

2.  Palliative arterial switch for transposition of the great arteries, ventricular septal defect, and pulmonary vascular obstructive disease: midterm outcomes.

Authors:  Bin-Feng Lei; Ji-Mei Chen; Jian-Zheng Cen; Raphael C Lui; Yi-Qun Ding; Gang Xu; Jian Zhuang
Journal:  J Thorac Cardiovasc Surg       Date:  2010-05-23       Impact factor: 5.209

3.  Flap valved closure of ventricular septal defects with increased pulmonary vascular resistance.

Authors:  Prasanna Simha Mohan Rao; Varadaraju Raju; Madhusudana Narayana
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-08-19

4.  A simple technique of unidirectional valved patch for closure of septal defects.

Authors:  Shiv Kumar Choudhary; Sachin Talwar; Balram Airan
Journal:  J Thorac Cardiovasc Surg       Date:  2007-11       Impact factor: 5.209

5.  Unidirectional valved patch closure of ventricular septal defect along with total repair in a 12-year-old patient with truncus arteriosus.

Authors:  Sachin Talwar; Anita Saxena; Ajay Meena; Shiv Kumar Choudhary; Balram Airan
Journal:  World J Pediatr Congenit Heart Surg       Date:  2013-01

6.  Arterial switch operation with unidirectional valved patch closure of ventricular septal defect in patients with transposition of great arteries and severe pulmonary hypertension.

Authors:  Sachin Talwar; Shiv Kumar Choudhary; Vinitha Viswambharan Nair; Sandeep Chauhan; Shyam Sunder Kothari; Rajnish Juneja; Anita Saxena; Balram Airan
Journal:  World J Pediatr Congenit Heart Surg       Date:  2012-01-01

7.  Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes.

Authors:  Sachin Talwar; Vikas Kumar Keshri; Shiv Kumar Choudhary; Saurabh Kumar Gupta; Sivasubramanian Ramakrishnan; Anita Saxena; Shyam Sunder Kothari; Rajnish Juneja; Guresh Kumar; Balram Airan
Journal:  J Thorac Cardiovasc Surg       Date:  2013-12-09       Impact factor: 5.209

8.  Unidirectional valved patches for closure of septal defects in patients with severe pulmonary hypertension.

Authors:  Sachin Talwar; Shiv Kumar Choudhary; Anita Saxena; Shyam Sunder Kothari; Rajnish Juneja; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2008-07

9.  Double patch closure of ventricular septal defect with increased pulmonary vascular resistance.

Authors:  W M Novick; A T Gurbuz; D C Watson; V V Lazorishinets; A N Perepeka; I Malcic; B Marinovic; B S Alpert; T G DiSessa
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.